Cuadero, Ronald A.

HRN: 29-48-13  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2026
CEFTRIAXONE 1G (VIAL)
08/13/2026
08/20/2026
IV
2G
OD
PENETRATING INJURY EPIGASTRIC AREA
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueIntra-abdominal    Compliance to guidelines: